Response to Comment on American Diabetes Association. Standards of Medical Care in Diabetes—2017 . Diabetes Care 2017;40(Suppl. 1):S1–S135

Abstract

We thank Sonne and Hemmingsen (1) for their thoughtful critique of the American Diabetes Association’s Standards of Medical Care in Diabetes—2017 (Standards of Care) (2). As they point out, the Standards of Care now highlight a prediabetes screening tool that was developed in 1995 (3), revised in 2012 (4), and most recently validated in 2016 (5). The Standards of Care also recommend regular monitoring for those with prediabetes, intensive lifestyle intervention for diabetes prevention, and consideration of metformin therapy for selected individuals with prediabetes (6). We acknowledge that the use of three different diagnostic tests to define prediabetes identifies heterogeneous groups. Although values above the diagnostic threshold for each of the tests have been associated with increased risk of progression to type 2 diabetes (T2D) (7,8), the thresholds for the individual …